ID   WA27
AC   CVCL_E082
SY   WAe027-A
DR   hPSCreg; WAe027-A
DR   ISCR; 2022
DR   NIHhESC; NIHhESC-12-0198
DR   WiCell; wa27
DR   Wikidata; Q54993534
RX   PubMed=28445466;
WW   https://www.wicell.org/media/Ads/2013.ISSCR.DerivationFinal.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0198.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa27
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 18
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//